The Core Difference
In litigation finance, 'non-recourse' and 'recourse' aren't just legal terms. They define your firm's entire risk profile. A non-recourse loan means the lender can only collect repayment from the proceeds of the cases that were financed. If those cases lose or settle for less than expected, you owe nothing beyond what your cases produce. Your personal assets, your home, your savings, all protected. A recourse loan, by contrast, gives the lender the right to pursue your personal assets or other firm assets if the financed cases don't generate enough to repay the loan.
Why Non-Recourse Costs More
Lenders charge higher interest rates for non-recourse structures because they're absorbing more risk. If your cases fail, they lose their investment entirely. This risk premium typically adds 3-8% to the interest rate compared to recourse alternatives. For many plaintiff firms, this premium is worth paying, the peace of mind and liability protection justify the additional cost, especially for riskier case categories like pharmaceutical litigation or emerging mass torts where outcomes are uncertain.
When Recourse Makes Sense
Recourse lending isn't always the wrong choice. For firms with strong, diversified portfolios and predictable settlement timelines, like established personal injury practices, recourse facilities offer significantly lower rates. If your historical data shows consistent performance and you're confident in your docket, the savings from a recourse structure can be substantial. Some firms use a hybrid approach: a recourse facility for their core PI portfolio and non-recourse financing for higher-risk mass tort investments.
How to Evaluate Your Options
Start by assessing your portfolio risk honestly. What percentage of your cases historically resolve favorably? What's your worst-case scenario? Then compare the total cost of each structure over your expected loan term. Factor in the value of personal liability protection. It's worth more than most attorneys realize until they need it. At Tortlink, we present both recourse and non-recourse options side by side so you can make an informed decision with complete transparency.
The Bottom Line
There's no universally 'right' answer, the best structure depends on your firm's specific situation, risk tolerance, and portfolio composition. What matters is understanding the tradeoffs before you sign. Too many firms accept the first term sheet they receive without understanding the recourse implications. That's a mistake that can have life-changing consequences if cases underperform.